
Chinese drug development company established on 14 November 2007 in the Huangpu district of Guangzhou, Guangdong, founded by returnee scientist Professor Wu Chuanbin, the first Chinese scientist elected a fellow of the American Association of Pharmaceutical Scientists. Works mainly on proprietary product research and development, supported by shared co-development and patented technology research services, covering medicines, nutritional health products and special cosmetics along with technical services and technology transfer. Runs four specialist formulation platforms in sustained and controlled release preparations, poorly soluble drugs, microsphere industrialisation and microneedle preparations, with a research team of doctorate and masters holders in medicine, pharmacy and chemistry of whom eighty per cent came from large pharmaceutical companies in China and abroad.
Unternehmensprofil ansehen
Bewertung hinterlassen